Everolimus
Everolimus (SDZ-RAD) is an orally active rapamycin derivative and selective mTOR1 inhibitor. It demonstrates immunosuppressive and anti-tumor properties by suppressing proliferation and promoting apoptosis and autophagy, making it a key tool for oncology and immunology research in both cellular and animal models.
Product Specifications
CAS Number
159351-69-6
Product Name Alternative
SDZ RAD; RAD001
Field of Research
Immunology & Inflammation
Purity
>98%
Bioactivity
MTOR inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 100 mg/ml) or in Ethanol (up to 100 mg/ml) .
Smiles
[H][C@@]12CC[C@@H] (C) [C@@] (O) (O1) C (=O) C (=O) N1CCCC[C@@]1 ([H]) C (=O) O[C@@] ([H]) (CC (=O) [C@H] (C) \C=C (C) \[C@@H] (O) [C@@H] (OC) C (=O) [C@H] (C) C[C@H] (C) \C=C\C=C\C=C (C) \[C@H] (C2) OC) [C@H] (C) C[C@@H]1CC[C@@H] (OCCO) [C@@H] (C1) OC
Molecular Formula
C53H84NO14
Molecular Weight
956.2
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
40-O- (2-Hydroxyethyl) rapamycin
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog